Bloomberg - Oct. 18 (Bloomberg) -- Wyeth earnings declined almost a percent as higher costs for a two-year-old productivity plan offset increased sales of the arthritis drug Enbrel and the pneumonia vaccine Prevnar. Third-quarter net income declined to $1.15 ...
